Entering text into the input field will update the search result below

Celldex misses by $0.07, beats on revenue

May 01, 2014 8:15 AM ETCelldex Therapeutics, Inc. (CLDX) StockBy: Mohit Manghnani, SA News Editor3 Comments
  • Celldex (NASDAQ:CLDX): Q1 EPS of -$0.33 misses by $0.07.
  • Revenue of $0.4M (-83.4% Y/Y) beats by $0.15M.
  • Press Release

Recommended For You

About CLDX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CLDX--
Celldex Therapeutics, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.